Position in DYN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$44,420
+$8,160 QoQ
Shares Held
2,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#188
of 245 holders
Holding Since
Sep 2025
4 quarters on record
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Chung Wu Investment Group, LLC holds $1,088,243 across 14 Biotechnology names. DYN ranks #7 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
1,500 | $280,920 | |
| 2 | SRRK |
Scholar Rock Holding Corp
|
3,500 | $192,500 | |
| 3 | PVLA |
Palvella Therapeutics, Inc.
|
1,100 | $168,102 | |
| 4 | SEPN |
Septerna, Inc.
|
4,800 | $160,752 | |
| 5 | TYRA |
Tyra Biosciences, Inc.
|
2,000 | $63,880 | |
| 6 | EQ |
Equillium, Inc.
|
16,500 | $52,800 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
This page
|
2,000 | $44,420 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
2,000 | $37,300 |
All Filings in DYN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,420 | 2,000 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $36,260 | 2,000 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $54,768 | 2,800 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $30,360 | 2,400 | Shares | Sole | 2025-11-04 | |
| No filing history on record for this holder in this stock. | ||||||